Uncategorized
Dr. Christina Charles-Schoeman, chief of rheumatology, recently published important findings from the FDA mandated post authorization, safety end-point trial, ORAL Surveillance, examining risk of major[...]
Department of Medicine
A community resource for faculty and staff